|
|
A phase Ⅱ study of gemcitabine and carboplatin combination chemotherapy in gallbladder carcinoma |
Pramod Kumar Julka, Tarun Puri and Goura Kishore Rath |
New Delhi, India
Author Affiliations: Department of Radiotherapy & Oncology, All India Institute of Medical Sciences, New Delhi, India (Julka PK, Puri T and Rath GK)
Corresponding Author: Pramod. K. Julka, MD, Department of Radiotherapy & Oncology, Amrit Kaur OPD Block, All India Institute of Medical Sciences, New Delhi-110029, India (Tel: +91-11-26589141; Fax: +91-11-26589243; Email: drjulka@rediffmail.com) |
|
|
Abstract BACKGROUND: Patients with carcinoma of the gallbladder have advanced, unresectable tumor at the time of presentation and face a dismal prognosis in the absence of a standard palliative chemotherapy regimen. This study was undertaken to evaluate the efficacy and safety of combined chemotherapy of gemcitabine and carboplatin in 20 patients with advanced gallbladder carcinoma.
METHODS: The criteria of eligibility included chemonaive patients with unresectable gallbladder cancer, bidimensionally measurable disease, Zubrod’s performance status≤2, and adequate major organ function. The patients received gemcitabine (1000 mg/m2) on days 1 and 8, and carboplatin (target AUC of 5.0 mg/ml) on day 1, in a 21-day cycle. CT was used for response assessment.
RESULTS: In this group of 20 patients with advanced gallbladder carcinoma 6 were men and 14 women, with a median age of 55 years. The stage of the tumor at presentation was IVB in 14 patients (70%), IVA in 3 (15%) and Ⅲ in 3 (15%). Four patients (21%) achieved a complete response, and 3 (15.7%), a partial response; an overall response rate was 36.7%. The median time to progression of the tumor was 33.8 weeks, and 1-year survival rate of the patients was 43.3%. Anemia of WHO grade Ⅲ or Ⅳ was seen in 2 patients (10%) and 1 patient (5%), respectively. Grade Ⅲ neutropenia and thrombocytopenia were observed in 2 patients (10%) and 1 patient (5%), respectively.
CONCLUSION: With mild toxicity, combined chemotherapy of gemcitabine and carboplatin is effective in the treatment of advanced gallbladder carcinoma.
|
|
|
|
|
|
|
|